oral glp 1 lilly is now pharma's top revenue company. It just got FDA approval for an GLP-1, but Wall Street isn't celebrating FDA just approved orforglipron (Foundayo),

One Variable Worth Checking B12 won't cure an anxiety disorder

Lilly Launches Trulicity in the US First Ever Ready-to-Use Once-Weekly GLP-1 Receptor Agonist Twitter summary: @LillyDiabetes launches Trulicity in the US first ready-to-use once-weekly GLP-1, available w/savings program for commercially insured On November 10, Eli Lilly and company announced that Trulicity (dulaglutide) is now available in the US, making it the first ready-to-use once weekly GLP-1 receptor agonist to reach the market (no mixing required)

Key Takeaway: Wegovy slows down the digestive process to promote fullness, but this delay can cause food and stomach acid to linger, potentially leading to reflux

No cardiovascular risks: The hypertension and cardiovascular events associated with EPO don't occur with ARA-290 because the pathways responsible aren't activated